Nuveen
TNXP icon

Nuveen’s Tonix Pharmaceuticals TNXP Stock Holding History

Nuveen’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
117,447
+22,886
+24% +$295K ﹤0.01% 2728
2026
Q1 		$1.3M Buy
94,561
+1,159
+1% +$17.8K ﹤0.01% 2466
2025
Q4 		$1.46M Buy
93,402
+78,033
+508% +$1.44M ﹤0.01% 2423
2025
Q3 		$371K Sell
15,369
-36,523
-70% -$1.36M ﹤0.01% 2993
2025
Q2 		$1.87M Buy
+51,892
New +$1.36M ﹤0.01% 2334
2022
Q2 		– Sell
-2
Closed -$315K – 3475
2022
Q1 		$315K Sell
2
-1
-33% -$153K ﹤0.01% 3116
2021
Q4 		$665K Hold
3
– – ﹤0.01% 2993
2021
Q3 		$1.07M Hold
3
– – ﹤0.01% 2969
2021
Q2 		$1.94M Buy
+3
New +$2.21M ﹤0.01% 2726

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nuveen's TNXP Position: Q2 2026 in Review

Nuveen increased its Tonix Pharmaceuticals (TNXP) stake by 24% in Q2 2026, buying an estimated $295K and bringing the position to 117,447 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2728.

Nuveen first reported a position in TNXP in Q2 2021 and has held it in 9 quarters since. The position peaked at $1.94M in Q2 2021. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Nuveen held 117,447 shares of Tonix Pharmaceuticals worth $1.5M as of Q2 2026.
  • Nuveen bought 22,886 Tonix Pharmaceuticals shares in Q2 2026, an estimated $295K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2728 holding.
  • Nuveen first reported a position in Tonix Pharmaceuticals in Q2 2021 and has held it in 9 quarters since.
  • Nuveen's Tonix Pharmaceuticals position peaked at $1.94M in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.